Abbott to cease sale of infant probiotic products after FDA warning
-Abbott Laboratories will stop sales of its Similac Probiotic Tri-Blend product used for hospitalized preterm infants after the U.S. Food and Drug Administration issued a warning letter, the health... -October 26, 2023 at 12:34 pm EDT - MarketScreener